InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Beardsley, Robert Alan. Director active across 1 company, notably Arbutus Biopharma Corporation. Cumulatively, 1 disclosures have been logged. History available since 8 June 2026. The latest transaction was disclosed on 8 June 2026 (50 - Grant of options). Regulator: SEDI. The full history is openly available.
1 of 1 declaration